Back
Catalent 10K Form
Sell
29
CTLT
Catalent
Last Price:
55.83
Seasonality Move:
11.53%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CTLT News And Ratings
See the #1 stock for the next 7 days that we like better than CTLT
CTLT Financial Statistics
Sales & Book Value
| Annual Sales: | $4.26B |
|---|---|
| Cash Flow: | $-62M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $19.96 |
| Price / Book: | 2.81 |
Profitability
| EPS (TTM): | -6.36000 |
|---|---|
| Net Income (TTM): | $-1.18B |
| Gross Margin: | $1.04B |
| Return on Equity: | -28.75% |
| Return on Assets: | -11.42% |
Catalent Earnings Forecast
Key Catalent Financial Ratios
- The Gross Profit Margin over the past 13 years for CTLT is 24.40%.
- The Selling, General & Administrative Expenses for CTLT have been equal to 19.45% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is -72.66% of Operating Income.
- The Net Earning history of CTLT is -6.01% of Total Revenues.
- Per Share Earnings over the last 13 years have been positive in 6 years.
Catalent Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | CTLT |
| CUSIP: | 148806 |
| Website: | catalent.com |
Debt
| Debt-to-Equity Ratio: | 1.38 |
|---|---|
| Current Ratio: | 2.51 |
| Quick Ratio: | 1.56 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 39.34 |